skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Products

Show More

Show More

100+ Total results for product and free and sample content found

Biomedtracker

Biomedtracker 2018 Early Outlook Report

28 Jul 2022

Biomedtracker 2018 Early Outlook Report

What's on the horizon for pharma in 2018? Find out with Biomedtracker's Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.

Topic Drug Development Landscape

Datamonitor Healthcare

Profitability Assessment of Branded Generic Inhalers

By Ljlal Syed, Mark Lansdell and David Abramson 28 Jul 2022

Profitability Assessment of Branded Generic Inhalers

This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic

Topic Deals

Datamonitor Healthcare

Immuno-Oncology Overview

By Colin White, Robert Jeng & Jolene Lau 28 Jul 2022

Immuno-Oncology Overview

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well

Topic immuno-oncology

Trialtrove

Expanded Curation of Immuno-Oncology Combination Trials in Trialtrove

01 Jul 2022

Expanded Curation of Immuno-Oncology Combination Trials in Trialtrove

To highlight the growing importance of IO and especially IO combination trials within oncology clinical development, visual trends and key insights about the past 20+ years were compiled.

Citeline

Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions

30 Jun 2022

Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions

The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to patient  

Citeline

Pharma R&D Annual Review 2022 Supplement: New Active Substances Launched During 2021

27 Jun 2022

Pharma R&D Annual Review 2022 Supplement: New Active Substances Launched During 2021

Following on from our review of trends in the current pharmaceutical R&D pipeline, this supplement takes a look at the industry’s success stories of 2021 – the drugs which were launched onto the market for the first time during the year. 

Citeline

Pharma R&D Annual Review 2022: Navigating the Landscape

27 Jun 2022

Pharma R&D Annual Review 2022: Navigating the Landscape

Take a look at the evolution of pharma R&D and in this article, examine the state of play at the start of 2022.

Citeline

2021 Completed Trials: Green Shoots of COVID-19 Recovery Become Apparent

27 Jun 2022

2021 Completed Trials: Green Shoots of COVID-19 Recovery Become Apparent

As the COVID-19 pandemic stretched through a second year, its impacts continued to reshape the clinical trials landscape.

Topic Clinical Trials

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: